Dataset Information


Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.

ABSTRACT: Direct oral anticoagulants (DOAC) are substrates for the ABCB1 transporter (also called P-glycoprotein), an active efflux pump. ABCB1 polymorphisms have been previously reported to influence the pharmacokinetics of several drugs such as immunosuppressants and tyrosine kinase inhibitors. Recently, in vivo studies have suggested that genetic variants might contribute to the inter-individual variability in DOAC plasma concentrations. Therefore, we evaluated the in vitro effect of the most common coding ABCB1 single nucleotide polymorphisms (SNP), 1236?C?>?T-2677G?>?T-3435C?>?T, and the coding ABCB1 1199?G?>?A SNP on the transport activity towards rivaroxaban. HEK293 cells were transfected to overexpress the ABCB1 wild-type (1236C-2677G-3435C, 1199?G) or variant proteins (1236C-2677G-3435T, 1236T-2677T-3435T or 1199?A). ABCB1 expression decreased the intracellular accumulation of rivaroxaban, when compared to control cells. This confirms the involvement of ABCB1 in the active transport of rivaroxaban. However, the ABCB1 1236?C?>?T-2677G?>?T-3435C?>?T and 1199?G?>?A SNPs had no significant influence on the intracellular accumulation of rivaroxaban when compared to the wild-type protein. These results suggest that the ABCB1 coding SNPs investigated in the present study are unlikely to contribute to the inter-individual variability in rivaroxaban plasma concentrations.

SUBMITTER: Sennesael AL 

PROVIDER: S-EPMC6043481 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2767284 | BioStudies
2018-01-01 | S-EPMC6060767 | BioStudies
2007-01-01 | S-EPMC1876748 | BioStudies
2016-01-01 | S-EPMC4941718 | BioStudies
2012-01-01 | S-EPMC3513228 | BioStudies
2016-01-01 | S-EPMC5013326 | BioStudies
2008-01-01 | S-EPMC2723795 | BioStudies
2018-01-01 | S-EPMC6231259 | BioStudies
2012-01-01 | S-EPMC3491093 | BioStudies
2018-01-01 | S-EPMC5754426 | BioStudies